Study finds melanoma spreads most in middle age

New research from Fox Chase Cancer Center shows that melanoma spreads more aggressively in middle-aged mice than in young or very old ones. The pattern appears linked to changes in a specific type of immune cell over time.

Researchers presented the findings at the American Association for Cancer Research annual meeting. Cancer spread reached its peak in middle-aged mice while remaining lower in young mice and declining again in very old mice. Mitchell Fane, the lead investigator, noted that most laboratory studies use only young mice, which limits understanding of how cancer behaves in older patients.

Verwandte Artikel

Illustration of abdominal fat cells related to aging and new fat generation.
Bild generiert von KI

Study links age-related belly fat to a newly identified fat-progenitor cell state

Von KI berichtet Bild generiert von KI Fakten geprüft

Researchers at City of Hope report that aging can spur the emergence of an age-enriched population of adipose progenitor cells that is especially prone to generating new fat cells in abdominal white fat. The work, published in Science, points to a signaling pathway that may help drive midlife increases in belly fat and could become a future therapeutic target.

New research in mice suggests that ovaries undergo significant changes after reproductive decline, potentially contributing to inflammation. Scientists found increased immune cell activity in aged ovaries.

Von KI berichtet

Researchers have identified how reduced levels of the GATA6 factor enable colorectal cancer cells to adopt a fetal-like state and metastasize to the liver. The findings point to epigenetic changes rather than genetic mutations as a key driver of this deadly progression.

Researchers have found that making cancer cells stiffer can enhance the effectiveness of car t-cell therapy against aggressive tumors. In experiments with mice, the approach led to complete tumor disappearance in some cases. The findings were presented recently at a conference in London.

Von KI berichtet

Researchers at Weill Cornell Medicine have developed tiny silica nanoparticles that destroyed aggressive prostate cancer tumors in mice while boosting the immune system. The treatment led to complete remissions when combined with immunotherapy.

Diese Website verwendet Cookies

Wir verwenden Cookies für Analysen, um unsere Website zu verbessern. Lesen Sie unsere Datenschutzrichtlinie für weitere Informationen.
Ablehnen